The Dairy Vet of the Year award, which is organised by the British Dairying Magazine and sponsored by Krka UK Ltd, recognises a veterinary surgeon for going the extra mile in helping to create a more positive, forward-thinking dairy industry.
In addition to her work as a farm vet, Sarah is also Technical Director at the TB Advisory Service (TBAS), which involves her overseeing and delivering training for new advisors, chairing technical board meetings and delivering farmer meetings across the country. She also provides bespoke advice to farmers in High Risk and Edge Areas of England, and is known for her compassion and understanding for those suffering a TB breakdown.
She is also a member of the TB Eradication and Advisory Group (TBEAG) for England, which advises government policy makers on all aspects of TB control in England.
Lindsay Heasman, Project Manager at TBAS, said: “Sarah is an authority on TB and understands the responsibility that comes with this role. She uses her position for good at all times and is prepared to make statements that are not always universally popular. By standing by her beliefs and dispelling misconceptions, she has won the respect of farmers across the country. Her dedication has, at times, come at personal cost, but her passion for eradicating bTB and support for farmers in achieving this goal never wavers.”
Sarah said: “I am just a farm vet doing the same job every farm vet does daily across the country. Through necessity, seeing my clients being devastated by TB breakdowns every day, I felt passionate about doing something about it. TBAS, my colleagues I am lucky to work with, and TBEAG have given me the platform to do this. I am very humbled that the judges though me worthy of the Award amongst the other hard-working vets."
Photo: Giles Brandreth, Charlotte Read, Sarah Tomlinson and Sean Sparling
The RCVS issued a reminder today that there is just over a month left before the 1 April deadline for all veterinary practice premises from which medicines are to be supplied to be registered with the College.
Just over 4,500 premises have applied for registration since November 2008. This includes about 750 premises not previously listed with the College, demonstrating the usefulness of the process, which will enable the government to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines.
From 1 April it will be an offence for a veterinary surgeon to supply a veterinary medicinal product from any practice premises not registered with the RCVS. On conviction, those committing the offence may be liable to prosecution, which may include a fine or prison sentence. Veterinary surgeons convicted of criminal offences are also considered by the College's Preliminary Investigation Committee to decide whether the conviction would affect the individual's fitness to practise and should be referred to the Disciplinary Committee.
In addition to ensuring their practice premises are registered, veterinary surgeons also need to keep a record of other places where medicines are stored, so these can be considered during an inspection - such as vets' homes or cars, or perhaps a charity premises from which veterinary work is carried out and where medicines are stored. Such records will not be published, although some of those premises may need to be registered in their own right.
Practices accredited under the RCVS Practice Standards Scheme will be inspected by the RCVS; non-compliance with medicines standards will be dealt with under the rules of the Scheme. The Veterinary Medicines Directorate (VMD) will carry out inspections of other registered premises to ensure compliance with the Veterinary Medicines Regulations. Where non-compliance is noted, the VMD will take a proportionate enforcement approach ranging from issuing advice to, where appropriate, serving an improvement notice or seizing medicines.
Till then, veterinary surgeons are advised to make due diligent attempts to source a UK-authorised product before considering importing an alternative medicine.
Procaine hydrochloride is used in farm animal medicine in particular, to provide local and regional anaesthesia for a range of procedures including calving, lambing, caesarean operations, castration and dehorning of cattle, with demand particularly high in the spring.
Simon Doherty, BVA President, said: "We’re pleased that VMD has issued some clarification to answer our concerns over procaine hydrochloride shortages. BVA had heard from some veterinary practices that they were only able to get hold of a fraction of what they needed, which would have resulted in a very acute impact on farm animal welfare. Although we had moved to get assurances sooner, we appreciate that there are formal routes for reporting and that the announcement of any shortage must be handled sensitively to avoid exacerbating the problem.
"VMD’s clarification is especially timely as this is a period of peak seasonal demand for these products. We will keep our members closely informed of any further developments."
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Janssen Animal Health has produced a new DVD called 'Fluke: That's a Fact', which is available free from the company.
The 18 minute film features TV presenter Michaela Strachan discussing the big issues surrounding fluke in sheep, such as the effects on productivity and fertility and the need to adapt treatment regimes to reflect the current challenge in the environment, weather patterns and the possibility of resistance to commonly used flukicides. There is also a section on Haemonchus, the Barber's Pole worm, as the parasite has been reported in a number of farms in the last few years.
According to the company, fluke is becoming increasingly common and is moving into new areas of the UK. There is increasing evidence that a single autumn / winter dose of flukicide may not always be enough to control the disease on some farms and more frequent dosing programmes are now often proposed that look more long term to reduce the level of the disease on farms, especially on those farms with high infection pressure. The film clearly explains these different approaches and the benefits of treating at various times of the year.
Janssen's Livestock Marketing Manager Nigel Underwood hopes the film will be a great educational tool that will help both farmers and SQPs better understand the disease: "With ten easy to watch sections, people will be able to listen to the whole story or just dip into those areas where they feel they need to know more. With her long standing interest in the countryside and wildlife, Michaela Strachan was the perfect choice to present what can be a rather complex story and I'm sure everyone will enjoy her clear explanation of the facts."
To request a DVD or for further information, please contact Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG. Tel 01494 567555 Fax 01494 567556 Email: ahealth@its.jnj.com www.janssenanimalhealth.com/uk
In the study, which was supported by MSD and led by Rosie Lyle of Bishopton Veterinary Group, 18 farmers placed temperature loggers in the fridge where they normally store vaccines. Temperatures were then monitored between February and April. Throughout this period, 89% of loggers recorded a temperature outside the 2–8°C range at least once, and 43% recorded temperatures outside this range more than 50% of the time.
The authors say that these findings raise potential concerns about vaccine efficacy.
Rosie found that 55% of the loggers recorded a temperature over 8°C, and 39% recorded a temperature below 2°C.
Across all the fridges monitored, the maximum temperature recorded was 12°C and the minimum was -11.5°C.
Rosie said: "This is a surprisingly wide range. Obviously, these findings are concerning for farmers as we know that both too high and too low temperatures can impair vaccine efficacy.
"Live vaccines tend to be particularly sensitive to elevated temperatures, whereas inactivated vaccines are more affected by freezing, especially when the adjuvant contains aluminium salts".
"It’s important for both farmers and vets to be aware of potential concerns about vaccine efficacy, given the possible impact on herd health and the potential for vaccine failure to reduce trust in vaccines and herd health recommendations".
In light of Rosie’s findings, other XLVets practices are now encouraging farmers to take action to improve medicine storage, including using max/min thermometers or temperature loggers to track fridge temperature, as well as taking steps to maximise the efficiency of each fridge.
Susan Goodfellow, Marketing Manager at XLVets, said: "We wouldn’t have known that this is an important issue to highlight to farmers without collecting the information, so Rosie’s study was very valuable.
"In the XLVets community, we support clinical leadership with these kind of projects – we actively collect data and make sure that farmers can benefit from the latest findings. As a group of independent practices working together, we can achieve much more than we could in isolation."
The Livestock Adviser of the Year Award recognises those who have made a real difference to the operations of livestock farmers.
Julian focuses on dairy cow health and his particular interests include nutrition and benchmarking herd performance. Amongst other things, he has helped one large Dorset dairy farm reduce its antibiotic usage by two thirds over an eight year period.
Julian said: "I was honoured to be named Livestock Adviser of the Year. This work is my passion – I love working together with farmers, getting involved in all aspects of herd management and thinking through different options to improve herd health and productivity."
Runners up for the award were Phil Baynes, Managing Director of Baynes Nutrition, and Ed Hill, veterinary surgeon at Thrums Veterinary Group.
Friars Moor, Baynes Nutrition and Thrums Veterinary Group are all members of the XLVets community of independent veterinary practices.
Alice Renner, Farm Marketing Executive of XLVets, said: "We were so pleased to hear of these awards going to such hard-working and deserving people. And it’s a great accolade for our members – reflecting how XLVets practices strive for clinical excellence and really get invested in the success of their clients."
The materials available include a scour management guide for farmers and a more detailed version for vets. They encourage a focus on three main areas for improved, sustained disease control: maximising calf immunity; identifying any causal agents and how to effectively manage an outbreak of calf scour on farm.
MSD Animal Health veterinary adviser Dr Kat Baxter-Smith (pictured right) said: "Even with good disease prevention protocols in place, calf scour outbreaks can still occur. But when they do, remedial action should focus on these three key areas to resolve the outbreak as quickly as possible and reduce the chances of another costly event happening in the future.
The company highlights a 202 survey of more than 300 farms, which found that over 80% of UK calf rearing units had seen a case of scour in the previous 12 months; with 50% of farms admitting to experiencing calf deaths due to the disease1. Costs are estimated at £57.94 per case but this does not include the longer-term impacts of the disease on future calf productivity.2,3
References
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.
Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".
Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''
For more information, ring 01248 725 400 or email: uksales@bimeda.com
Over the next few weeks, experts from the fields of veterinary science, academia and government will be offering sector-specific insight into key achievements, latest research and future action needed to tackle AMR through a number of blog posts published on www.bva.co.uk/BVA-blog.
Bloggers will include BVA President John Fishwick, presidents of several BVA specialist divisions, leading academics, and heads of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the National Office of Animal Health (NOAH), among others.
AMR poses a global threat to human and animal health and requires concerted efforts across the medical and veterinary professions to steward responsible use and prescription, as recognised in the UK Government-commission global Review on Antimicrobial Resistance, chaired by Lord O’Neill (May 2016).
The veterinary profession in the UK has been committed to the responsible use of antimicrobials, with the Chief Medical Officer publicly recognising the concerted efforts to reduce antibiotic usage in agriculture. BVA is a member of RUMA and has been working closely with stakeholders in government and industry to develop appropriate and evidence based targets across the livestock sector, which will be announced tomorrow (27 October) at a conference in London.
British Veterinary Association Senior Vice President Gudrun Ravetz said: "AMR is a serious global One Health issue that the veterinary profession is deeply concerned about, as it threatens our ability to treat animals and protect human health, and it is an issue BVA is addressing through joined-up working with UK governments, industry and other health sectors. Increased collaboration between the health sectors, underpinned by a commitment from each of us within the veterinary profession to maintain the highest standards of stewardship in using antimicrobials, most especially Critically Important Antibiotics, is the only way we can preserve these essential medicines for future generations.
"The blog series highlights various aspects of AMR by experts in their field, and we hope that throwing a spotlight on various sectors’ achievements so far and suggested steps for the future will help keep this important issue on all of our agendas, where it should be."
AMR discussions will continue at BVA Congress at the London Vet Show (16-17 November) with a Friday afternoon session on ‘The psychology of antimicrobial resistance: what can social science tell us?’, featuring David Brodbelt, Professor of Evidence-based Veterinary Medicine at Royal Veterinary College; Ian Donald,Emeritus Professor of Psychology and Director, Mulberry Research & Consulting Ltd, and Kristen Reyher, Senior Lecturer in Farm Animal Science at the University of Bristol.
To read Nigel Gibbens’s blog and other blogs from the series, see https://www.bva.co.uk/news-campaigns-and-policy/bva-community/bva-blog/safeguarding-the-future-of-antibiotics-is-our-moral-responsibility-as-vets/ and follow the ‘#AMRinfocus’ hashtag on social media.
Forte highlights that Utertab's intrauterine administration allows it to act directly in the target tissue. It is presented in a perforated blister pack for better sealing.
Dr John Henderson, Large Animal Product Manager at Forte Healthcare Ltd said: "Given the need to use appropriate first-line antibacterial drugs where possible we are delighted to bring vets a new Tetracycline pessary, ‘Utertab’, for the treatment of metritis and retained foetal membranes.
"In-situ therapy for these conditions has more recently been neglected in favour of injectables but still has much to recommend it. We look forward to highlighting these benefits over the next few months."
For further information on Utertab 2000mg, contact your local Forte Territory Manager or enquiries@fortehealthcare.com.
Newmarket-based Test and Treat was one of three finalists, for its U-Treat test which enables vets to diagnose a UTI and get antibiotic sensitivity results in an hour.
Rachel Kirkby MRCVS, Business Development Director at Test and Treat, said: "It’s a great accolade to be recognised by such a prestigious award. The Vet Record Innovation Award celebrates new innovations that can bring about improvement and make a real difference to vets in practice – and that’s exactly what we’re aiming to do with U-Treat.”
The second finalist was the Animal Welfare Assessment Grid, developed by Public Health England (PHE), in collaboration with the University of Surrey School of Veterinary Medicine. Initially developed in zoos, rescue and research centres, there are plans now to develop it for use in small animal practice and in the farm sector.
The overall winner was PBD Biotech for Actiphage, its test for bTB and Johne's disease which gives very early detection, thereby allowing vets and farmers to prevent the spread of infection.
For more information, visit: https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.267
The first, 'Factors that determine the success of a mastitis treatment' is tomorrow, Thursday 30th April, at 7:30pm. It will be presented by veterinary surgeon and researcher, Sofie Piepers.
The second webinar is titled 'Communication skills for effecting behaviour change with a focus on mastitis treatments'. Presented by Owen Atkinson, a vet with experience of the dairy industry around the world, the webinar will start at 7:30pm on Tuesday 5th May.
There will be opportunities to ask questions of both speakers at the end of each session.
For more information, visit: https://www.boehringer-academy.co.uk
The kit contains the ergonomically designed Henke-Sass Wolf injector with an adjustable dose selector, five single piece Intranasal RSP nozzles – with ‘luer’ lock attachment, which supports easier removal, cleaning and/or replacement – and instructions for use.
For more information, contact your local MSD Animal Health account manager.
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.
Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.
Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.
NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements".
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
Outstanding veterinary surgeons, veterinary nurses, animal welfare professionals and animal welfare teams can now be nominated to receive an award by their peers and the general public. Nominees can come from all walks of life, all ages, and from anywhere in the world.
The award categories include:
The Chris Laurence Vet of the Year Award supported by Your Dog and Your Cat magazinesThis award is in recognition of a veterinary surgeon working in practice that follows the footsteps of head judge, Chris Laurence, by educating pet owners and consistently demonstrating their commitment to the continued improvement of animal welfare.
Vet Nurse of the Year supported by Agria Pet InsuranceThis award is to give recognition to a veterinary nurse working in practice, who has shown real commitment to improving and championing excellent animal welfare within their surgery.
Charity Team of the Year supported by PDSAThis award is for an awe-inspiring team whose drive, passion and dedication has changed the lives of animals for the better, improving the standard of animal welfare where they can and working tirelessly to promote and champion their cause.
Charitable Contribution of the Year supported by Blue Cross This award is for an individual who works within a charity, either in a paid or voluntary role, who is consistently driven to the best of their ability, with a single-minded goal of helping save and improve the lives of animals in need.
Farm Animal Welfare Award supported by R.A.B.I. and NADISThis award is for an individual or team which have dedicated their careers to the health and welfare of production animals.
International Cat Care Welfare Award supported by International Cat CareThis award recognises an individual who has made a significant contribution to the development of feline welfare. The recipient of the award is chosen by International Cat Care and therefore the category is not open to nominations.
Since the first Ceva Awards in 2010, hundreds of people and teams have been nominated, with the winners decided by a panel of judges including Christopher Laurence MBE BVSc and James Yeates, chief veterinarian at RSPCA.
The winners and runners up will be honoured at a ceremony taking place on the eve of BSAVA Congress on 4th April 2018.
Ceva Animal Health managing director, Cuneyt Seckin said: "Over the last eight years we have been consistently humbled by the inspirational nominations that we receive from all over the world and we envisage this year to be no exception.
"The Ceva Animal Welfare Awards champion people involved in animal welfare, but they also raise awareness of this important work to wider audiences."
If there is a veterinary surgeon, nurse, animal welfare professional or animal welfare team that you feel deserves to be recognised for their ongoing commitment to animal welfare, visit www.cevawelfareawards.com to nominate.
Entries must be in by Friday 26 January 2018.
Ceva Animal Health has launched PRID Delta, described as an improved intra-vaginal progesterone device for the synchronisation of oestrus in cycling and non-cycling cattle.
The company says it has used its 35 years of expertise in cattle fertility to develop PRID Delta, and that trials have demonstrated that the new device provides optimal progesterone release, preserved efficacy and high retention rates.
Ceva claims the special triangular shape and bi-material fabric of PRID Delta ensures maximum contact with vaginal mucosa to release optimal levels of progesterone at insertion and during treatment. The new PRID Delta continues to give a bigger progesterone peak after insertion as with the original PRID.
According to the company, clinical and field trials observing oestrus occurrence and fertility at fixed time artificial insemination have shown a preserved efficacy for PRID Delta. PRID Delta is licensed for oestrus synchronisation in both cycling and non cycling cows. It is licensed for fixed time AI. Trials have also confirmed that PRID Delta is quick and easy to insert, is well tolerated and has a retention rate of over 97%.
Ceva has recently introduced a new website www.reprology.com/ for technical advice on the best solutions for the management of cattle reproduction. For further information contact your Ceva sales representative or Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com/
Scientists at the University of Liverpool have, for the first time, revealed that digital dermatitis (DD) has been present on hoof knifes used on cattle and sheep following research1 jointly funded by DairyCo and EBLEX.
The research conducted at the University investigated if DD Treponeme can be present on equipment used to trim cattle and sheep hooves. The research team, led by Dr Nicholas Evans and Professor Stuart Carter of the University of Liverpool and in collaboration with Roger Blowey MRCVS, tested trimming equipment used on cattle and sheep with digital dermatitis and after it was disinfected.
After trimming, DD was present on 97% of cattle blades and 100% of sheep blades. This was reduced to 29% and 46% respectively after disinfection.
Dr Evans said: "It has long been considered that digital dermatitis was spread in slurry which we have some evidence for and are continuing to investigate but now, for the first time, we have discovered the digital dermatitis bugs in the farm environment.
"However, the high detection rate of digital dermatitis bacteria on trimming blades soon after trimming cattle and sheep hooves from digital dermatitis cases suggests this may be a significant and worrying route for the transmission of this infectious condition."
Leigh Sullivan, who conducted the field work as part of her study, said: "Interestingly, in the world of human dentistry, a completely different species of the bacteria is found to cause gum disease. Furthermore, studies have shown it will adhere to metal on orthodontic braces which is consistent with our detection of the digital dermatitis Treponeme on metallic trimming knives."
Dr Jenny Gibbons, DairyCo research & development manager, added: "This DairyCo and EBLEX-funded study could help farmers, vets and hoof trimmers to understand more about the transmission of digital dermatitis between cows and farms. A logical precaution to limit the spread is to disinfect hoof trimming equipment between animals and between farms."
To find out more about this and other R&D projects, DairyCo is hosting a research day on 17 July at Trenault Farm, Launceston, Cornwall.
To book a place, visit: dairyco.org.uk/researchday2014
Reference
Loseley, the ice-cream maker, has announced that it has developed a new way of making flavoured ice-cream by adapting the diet fed to its cows.
The first variety to be made using the new technique is 'Eton Mess', for which the company's herd is being fed a diet of strawberries and meringues.
Loseley says its cattle - which are housed at the Beechdean Dairies farm in Buckinghamshire - have already been feeding on the ingredients found in the much loved pudding for over a year, to ensure their milk supply is infused with the strawberry and meringue flavours. Apparently, huge amounts of strawberries are having to be air-freighted into the UK in order to ensure an uninterrupted supply through the seasons.Andrew Howard Managing Director of Beechdean Dairies said: "We have been perfecting the quantities in the cattle feed for over 18 months to perfect the Eton Mess flavour. The cows need to be fed just the right quantities of meringues, strawberries, fat and hay to make the perfect Eton Mess ice cream. We believe ice cream should be great quality, tasty and interesting. Our products will always deliver against these criteria."Vince Bamford, Fast Moving Consumer Goods Editor at The Grocer, the UK's leading grocery trade magazine said: "Loseley's flavour development process is cutting edge - I have tasted the product and it is delicious. It is an exciting innovation for the ice cream category."
The BBC reports that a new strain of MRSA has emerged in British cows and is thought to be infecting humans.
For more on this story, click here.
The study, which examined cattle farmers’ and veterinary surgeons' opinions of pain-induced distress associated with disbudding, analgesia and attitudes and the use of non-steroidal anti-inflammatory drugs (NSAIDs), suggests that in particular, vets need to refine their understanding of farmers’ priorities, and how they guide clients on methods to improve calf welfare.
There have been a number of studies into the pain-induced distress resulting from the disbudding procedure. All methods of disbudding (apart from chemical cauterisation) in the UK require the use of a corneal nerve local anaesthetic blockade but there are currently no legislative requirements for the use of NSAIDs for disbudding – it is at the discretion of the farmer or veterinary surgeon carrying out the procedure. NSAIDs are routinely used in companion animals and equine practice, but less so in farm animals.
This new study, conducted by researchers at the Royal Veterinary College (RVC) in Hertfordshire and Aran Vet Clinic in Gwynedd, looked at the attitudes of farmers and vets on pain perception and pain management methods for disbudding. A total of 118 vets and 140 farmers contributed to the study. Of the respondents:
The study concluded that veterinary surgeons underestimate the influences of welfare and analgesic duration and effectiveness on farmers' decisions, and overrated cost impact. This perception could have a negative effect on veterinary recommendation.
The authors of the study therefore advise that steps should be taken to address the current inadequacies in the communications between vets and clients in conveying the practicalities and potential benefits of using NSAIDs.
Dr Troy Gibson, PhD, PGDipSci, BSc, Lecturer in Animal Welfare Science at the Royal Veterinary College said: "Despite the large amount of evidence of the benefits of NSAIDs for disbudding, it is disappointing that their use is still not widespread. This may partly be due to the only recent licencing of one NSAID for cattle. However, from our work it is clear that one of the key barriers to wider uptake is the breakdown in communication between veterinarians and their clients in conveying the cost, practicalities and potential benefits of NSAID use for disbudding. The wider use of NSAIDs in combination with local anaesthetics during disbudding would significantly improve calf welfare."